Information on causes of death (CoD) is essential for planning, implementing, monitoring, and evaluating public health at all levels. However, death registration and CoD determination do not happen for many deaths occurring in low- and middle-income countries (LMICs), and the deaths of poorer people are much less likely to be recorded, compounding inequalities. Statistical modelling is used to fill the data gaps, for example, for maternal deaths and malaria mortality. Facilitating complete and accurate CoD determination and death registration in LMICs is therefore a high priority. In the medium-term, this will involve applying verbal autopsy (VA) not only in surveillance sites and household surveys but also as a routine part of civil registration and vital statistics (CRVS) systems ([@CIT0001], [@CIT0002]).

VA ascertains probable CoD through interviews carried out with caretakers of the deceased or witnesses of deaths. The method uses questionnaires to elicit pertinent information on signs, symptoms, and circumstances leading to death, generically described as indicators, which are subsequently interpreted into CoD. VA has been increasingly used in various contexts including disease surveillance, sample registration systems, outbreak investigation, and measuring the impact of public health interventions. Because vital registration coverage has not significantly improved in most LMICs, VA data collection has been conducted in a variety of settings such as clinical trials and large-scale epidemiological studies; demographic surveillance systems; national sample surveillance systems; and household surveys. The expanding use of VA in generating mortality data has led to a proliferation of different VA instruments (comprising a set of questions/indicators that elicit pertinent information on signs, symptoms and circumstances preceding death and a corresponding list of CoD) that has impaired data comparability across sites and over time. Limited attention has been given to standardization of CoD interpretation from VAs ([@CIT0003]).

Users have different perspectives on the required level of accuracy and categories of cause-specific mortality data, with corresponding impacts on desirable characteristics of VA instruments ([@CIT0004]). However, the need for regular nationally representative cause-specific mortality data in settings where a significant proportion of deaths are not medically certified can only be met by death registration including VA as part of national CRVS systems. This requires simpler VA instruments and operating procedures that can produce timely, readily usable and reliable cause-specific mortality data.

To produce a simplified VA instrument, the World Health Organization (WHO) carried out a systematic review of VA instruments and procedures, followed by an expert consultation. Based on accumulated experience from widely-used and validated VA procedures, consensus was reached on a simplified VA instrument for routine use in CRVS systems where deaths are not medically certified. The 2012 WHO VA instrument comprises a short CoD list aligned to the International Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) that is ascertainable from a limited number of indicators and amenable to automated processing. The design allows adding a narrative and locally relevant questions and diagnoses as needed. The rationale and processes used to develop the 2012 WHO VA instrument are presented in this article.

VA instruments and procedures {#S0001}
=============================

The WHO first encouraged the use of lay reporting of health information in 1956, and from then through the 1990s, developed lay reporting forms and published key design features for studies based on VA methods. With the expanding diversity and use of VA instruments, demands for standardization led to the development of the WHO VA standards in 2007 that included ([@CIT0005]):VA questionnaires for three age groups (under 4 weeks; 4 weeks to 14 years; and 15 years and above);CoD certification and coding resources consistent with ICD-10; andA CoD list for VA prepared according to the ICD-10.

The 2007 WHO VA standards were partially based on a VA instrument developed by the London School of Hygiene and Tropical Medicine (LSHTM). The WHO standards expected that up to three physicians trained in VA coding would independently review individual questionnaire data -- known as physician-certified VA (PCVA). This procedure has been used by the International Network for the Demographic Evaluation of Populations and their Health in Developing Countries (INDEPTH)[1](#FN0002){ref-type="fn"} and by the Sample Vital Registration with Verbal Autopsy (SAVVY).[2](#FN0003){ref-type="fn"}

However, since PCVA is time-consuming and expensive, computerized coding of VA (CCVA) methods for interpreting VA data have been investigated. Validated CCVA methods can be algorithmic or probabilistic. Algorithmic methods follow a set of predefined diagnostic criteria that can be expert- or data-derived. The Tariff method is an additive algorithm that uses Tariff scores reflecting the importance and uniqueness of each symptom to each CoD. The Artificial Neural Network (ANN) method uses computer algorithms (machine learning), applying non-linear statistics to pattern recognition. The Random Forests method is a machine learning method for interpreting VA based on patterns of indicators from a 'training dataset' ([@CIT0006]). Whereas algorithmic methods result in binary outcomes (yes or no) for a single CoD, probabilistic methods determine the probability of a range of multiple causes. The InterVA method applies Bayesian probabilistic methods to a matrix of indicators and CoD, using conditional probabilities derived from available data and expert opinion. This method has been available in the public domain since 2006 ([@CIT0007], [@CIT0008]). King and Lu\'s algorithmic method is able to estimate cause-specific mortality fractions (CSMFs) without individual CoD assignment. The Simplified Symptom Pattern (SSP) method is a data-driven Bayesian approach that combines the King and Lu and InterVA methods.

Review of utilization of VA instruments and procedures {#S0002}
======================================================

Despite attempts to standardize and harmonize VA instruments, there are multiple instruments in use ([@CIT0009]--[@CIT0011]). We conducted a systematic literature review to determine how VA instruments have been used and the uptake of the WHO VA standards published in 2007.

The review included studies reported in peer-reviewed journals from 1986 up to early 2012. [Figure 1](#F0001){ref-type="fig"} illustrates the review process. The WHO instruments and the three related ones briefly described above (INDEPTH, SAVVY and LSHTM) were included in the review. Instruments described as adapted from these were also included. Studies that did not provide details of the instrument used were excluded. A brief description of the 125 eligible studies is available as a Supplementary File.

![Illustration of literature search and review process.](GHA-6-21518-g001){#F0001}

Some studies applied different VA interpretation methods on the same dataset and were counted as a single study for the review of the use of the VA instruments. The selected VA instruments or their adaptations were reported to be used by 112 studies in 41 countries. [Table 1](#T0001){ref-type="table"} summarizes the identified studies, data collection period, and number of deaths certified, by each VA instrument. VA was mostly used as a research tool in longitudinal health and demographic surveillance and in intervention or epidemiological studies. The first study identified used an adapted version of an early WHO instrument to certify perinatal deaths in Nepal in 1989 ([@CIT0012]). From the 112 reviewed studies, 104 reported the number of deaths certified, totalling 159,316. Studies using the INDEPTH instrument certified the largest number of deaths, ranging from 100 to 38,306 deaths with a mean of 4269.4, totalling 72,579 deaths ([Table 1](#T0001){ref-type="table"}).

###### 

Summary characteristics of reviewed studies (*n*=112) by type of VA instrument[a](#TF0001){ref-type="table-fn"}

                                                                                     \% of studies with sites          
  ------------------------------- ------------ ------------ ------------------------ -------------------------- ------ ------
  WHO VA instrument               31 (27.7%)   1992--2010   620.1 (23--4 239)        61.3                       32.3   16.1
  Adapted WHO VA instrument       42 (37.5%)   1989--2010   1 347.5 (2--12 542)      35.7                       59.5   7.1
  INDEPTH VA instrument           17 (15.2%)   1996--2009   4 269.4 (100--38 306)    64.7                       35.3   0
  Adapted INDEPTH VA instrument   9 (8%)       1999--2010   590.7 (164--1 816)       100                        0      0
  SAVVY instrument                1 (0.9%)     2007--2010   145                      100                        0      0
  Adapted SAVVY instrument        3 (2.7%)     2006--2008   258 (252--264)           33.3                       0      66.7
  LSHTM VA instrument             5 (4.5%)     1992--2002   407.3 (40--796)          80                         20     0
  Adapted LSHTM VA instrument     4 (3.6%)     2003--2007   2 304.3 (1 084--5 160)   25                         75     0

Percentages of studies conducted amount to more than 100% because some multicentre studies had sites in more than one continent.

VA has also been applied in national health surveys. In most surveys (e.g. Nepal Demographic and Health Survey (DHS) 2006, Ghana DHS 2008, Bangladesh DHS 2011), this involves the identification of deaths among children under 5 years in either the household schedule or the individual interview of women of reproductive age, followed by administration of a VA module. In Uganda, deaths among children under 5 identified in the DHS in 2007 were followed up in a subsequent survey in 2008. In the Afghanistan Mortality Survey 2010, a VA was administered for deaths of all ages. In Mozambique, a post census VA was conducted in 2008. All surveys ask for medical certification of the CoD, but the majority rely on VA using a variety of questionnaires.

[Table 1](#T0001){ref-type="table"} and [Fig. 2](#F0002){ref-type="fig"} show that the majority of reviewed studies had sites in Africa (54.5%) and Asia (40.2%), while some were conducted in Central and South America (8.9%). The majority of studies using the WHO (61.3%), INDEPTH (64.7%) or adapted versions of the INDEPTH instruments (100%) were in Africa; studies using the WHO (32.3%) or INDEPTH (35.3%) instruments also had sites in Asia.
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Use over time for each VA instrument is shown in [Fig. 3](#F0003){ref-type="fig"}. Publications using the WHO and INDEPTH VA instruments (and adaptations) increased around 1999, peaking between 2003 and 2005. There have been a limited number of published studies using other instruments. Since the publication of the WHO VA standards in 2007, 17 studies have been conducted which used the WHO VA instrument and adaptations (12/17); the INDEPTH instrument and adaptations (2/17); and the SAVVY instrument and adaptations (3/17). While these figures show that the majority of studies since 2007 have used the WHO VA instrument and adaptations, it is difficult to assess the level of uptake of the WHO VA standards, as trends in more recent data collection years may be difficult to interpret due to delays in publication of results, particularly given delays in PCVA interpretation in some sites.

![Use of different VA instruments over time.](GHA-6-21518-g003){#F0003}

Age groups were reported by 110 studies. For comparisons, age groups were categorized non-exclusively as: stillbirths; under 4 weeks; 4 weeks to 5 years; under 15 years; 15 years and above; maternal deaths; and all age groups ([Table 2](#T0002){ref-type="table"}). VA instruments have mostly been used for 15 years and above (26.4%) and for all age groups (22.7%). Deaths in children under 5 years old (18.2%) and neonates (18.2%) have also been widely studied.

###### 

Age groups studied by type of VA instrument (*n*=110)[a](#TF0001){ref-type="table-fn"}

                                  Stillbirths    Under 4 weeks    Under 5 years    Under 15 years   Aged 15 years and above   Maternal deaths   All age groups
  ------------------------------- -------------- ---------------- ---------------- ---------------- ------------------------- ----------------- ----------------
  WHO VA instrument               13.3% (4/30)   20.0% (6/30)     30.0% (9/30)     3.3% (1/30)      13.3% (7/30)              10.0% (3/30)      10.0% (3/30)
  Adapted WHO VA instrument       7.3% (3/41)    24.4% (10/41)    17.1% (7/41)     0% (0/41)        17.1% (7/41)              17.1% (7/41)      26.8% (11/41)
  INDEPTH VA instrument           5.9% (1/17)    11.8% (2/17)     11.8% (2/17)     11.8% (2/17)     17.6% (3/17)              0% (0/17)         47.1% (8/17)
  Adapted INDEPTH VA instrument   0% (0/9)       0% (0/9)         22.2% (2/9)      33.3% (3/9)      33.3% (3/9)               0% (0/9)          11.1% (1/9)
  SAVVY instrument                0% (0/1)       0% (0/1)         0% (0/1)         0% (0/1)         100.0% (1/1)              0% (0/0)          0% (0/0)
  Adapted SAVVY instrument        33.3% (1/3)    66.7% (2/3)      0% (0/3)         0% (0/3)         33.3% (1/3)               0% (0/3)          0% (0/3)
  LSHTM VA instrument             0% (0/5)       0% (0/5)         0% (0/5)         0% (0/5)         100.0% (5/5)              0% (0/5)          0% (0/5)
  Adapted LSHTM VA instrument     0% (0/4)       0% (0/4)         0% (0/4)         0% (0/4)         50.0% (2/4)               0% (0/4)          50.0% (2/4)
  Total                           8.2% (9/110)   18.2% (20/110)   18.2% (20/110)   5.5% (6/110)     26.4% (29/110)            9.1% (10/110)     22.7% (25/110)

Percentages do not add up to 100% as some studies determined CoD in more than one age group.

The most common interpretation method (more than one was used in some studies) was the PCVA (82.9%), followed by probabilistic methods (11.7%), and algorithms (10.8%) ([@CIT0002]). Of probabilistic methods, InterVA was most used (61.5%). Only one study used ANN, Random Forest, SSP, Tariff, or King and Lu methods to ascertain CoD.

Validity studies for VA procedures are fraught with difficulties since there is no widely available gold standard, particularly for the majority of LMICs deaths not occurring in health facilities ([@CIT0013]). The validity of VA is typically assessed by comparing hospital medical records as gold standard diagnoses for CoD, as well as by making between-method comparisons (e.g. between PCVA and CCVA). The validity of the overall VA process is influenced by the design and content of the questionnaires, field procedures, data interpretation methods, actual CoD patterns, and characteristics of the deceased ([@CIT0014]).

Of the 125 studies reviewed, 26 assessed performance of VA procedures in certifying CoD (studies using the same VA dataset but different CoD interpretation methods and/or assessing different validation parameters were included in the review and counted as individual studies) ([Table 3](#T0003){ref-type="table"} and [4](#T0004){ref-type="table"}). Apart from adapted versions of the LSHTM VA instrument, all other types of VA instruments have been validated at least once by these studies. The majority of studies validating VA procedures have used the WHO VA instrument (6/26) and their adapted versions (10/26). A similar review by Chandramohan et al. in 1994 identified almost no information on the validity of VA for adult deaths ([@CIT0007]). Our review identified that this trend has shifted with most of the 26 studies having assessed the performance for all CoD (21/26), in adults (10/26) and in all age groups (10/26). These studies used a variety of measures, including: sensitivity (14/26); specificity (14/26); positive predictive value (PPV) (8/26); negative predictive value (NPV) (4/26); cause-specific fractions (CSF) (1/26); concordance between CSMF estimated by VA and CSMF from the validation data (10/26); areas under the receiver operator characteristic (ROC) curve (3/26); kappa statistics (7/26); cause-specific and average chance-corrected concordance (5/26); CSMF accuracy (6/26); and cause-specific concordance correlation coefficients of estimated CSMFs compared to true CSMFs (6/26). The ability of these studies to adequately validate VA has often been limited by small sample sizes, affecting reliability of measures such as sensitivity and specificity, and the absence of certain causes from hospital data. Most studies (20/26) relied on hospital CoD data as the standard measure of validity. Exceptions included comparison studies using the InterVA method (7/26), where in five studies the reliability of VA procedure was assessed by the concordance of CSMFs estimated by InterVA and PCVA. The review found two studies validating the performance of InterVA against hospital CoD data ([@CIT0008], [@CIT0033]).

###### 

Main characteristics of reviewed VA validation studies (*n*=26)

  Number of validation studies            Measures of validity   Validated against hospital CoD data                                                                   
  --------------------------------------- ---------------------- ------------------------------------- ------ ------ ------ ------- ------ ------ ------ ------ ------ -------
  WHO VA instrument (*n*=6)               6/6                    6/6                                   2/6    2/6    1/6    1/6     1/6    0/6    0/6    0/6    0/6    6/6
  Adapted WHO VA instrument (*n*=10)      3/10                   2/10                                  2/10   1/10   0/10   2/10    0/10   2/10   5/10   6/10   6/10   9/10
  INDEPTH VA instrument (*n*=3)           0/3                    0/3                                   0/3    0/3    0/3    2/3     0/3    2/3    0/3    0/3    0/3    0/3
  Adapted INDEPTH VA instrument (*n*=1)   1/1                    1/1                                   1/1    0/1    0/1    1/1     1/1    1/1    0/1    0/1    0/1    0/1
  SAVVY instrument (*n*=1)                1/1                    1/1                                   1/1    1/1    0/1    1/1     1/1    1/1    0/1    0/1    0/1    1/1
  Adapted SAVVY instrument (*n*=1)        0/1                    1/1                                   1/1    0/1    0/1    0/1     0/1    0/1    0/1    0/1    0/1    0/1
  LSHTM VA instrument (*n*=4)             3/4                    3/4                                   1/4    0/4    0/4    3/4     0/4    1/4    0/4    0/4    0/4    4/4
  Total (*n*=26)                          14/26                  14/26                                 8/26   4/26   1/26   10/26   3/26   7/26   5/26   6/26   6/26   20/26

###### 

List of reviewed VA validation studies (*n*=26)

  Instrument and source                        VA interpretation method                                          Number of deaths certified   CoD studied                    Age groups studied                  Validity and reliability parameters
  -------------------------------------------- ----------------------------------------------------------------- ---------------------------- ------------------------------ ----------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  WHO VA instrument ([@CIT0015])               Physician review                                                  225                          All causes                     Stillbirths                         Sensitivity, Specificity, PPV, NPV, ROC curves
  WHO VA instrument ([@CIT0016])               Algorithms                                                        1115                         Diarrhoea and pneumonia        Children under 5 years              Sensitivity, Specificity, CSMF
  WHO VA instrument ([@CIT0017])               Physician review                                                  719                          All causes                     Children under 5 years              Sensitivity, Specificity, PPV, Difference between CSMF estimated by VA and true CSMF in validation data
  WHO VA instrument ([@CIT0018])               Physician review                                                  763                          Stroke                         Adults                              Sensitivity, Specificity
  WHO VA instrument ([@CIT0019])               Physician review                                                  1 251                        All causes                     Stillbirths and neonates            Sensitivity, Specificity
  WHO VA instrument ([@CIT0020])               Physician review                                                  36                           Selected childhood illnesses   Children under 12 years old         Sensitivity, Specificity, PPV, NPV
  Adapted WHO VA instrument ([@CIT0021])       Physician review                                                  255                          All causes                     All age groups                      Sensitivity, Specificity
  Adapted WHO VA instrument ([@CIT0022])       Physician review                                                  219                          All causes                     Adults                              Sensitivity, Specificity, PPV, NPV, Kappa statistics
  Adapted WHO VA instrument ([@CIT0023])       Physician review and InterVA                                      734                          All causes                     Stillbirths and neonates            Concordance of CSMFs estimated by InterVA and physician review, Level of agreement between InterVA and physician assigned CoD using Kappa statistics
  Adapted WHO VA instrument ([@CIT0024])       Physician review                                                  9 817                        All causes                     All age groups                      Sensitivity, PPV, Concordance of CSMFs estimated by physician review and medical record diagnoses
  Adapted WHO VA instrument ([@CIT0008])       InterVA, physician review and SP method                           12 542                       All causes                     All age groups                      Average of cause-specific chance-corrected concordance, CSMF accuracy, relationship between estimated CSMFs and true CSMFs
  Adapted WHO VA instrument ([@CIT0025])       King Lu method and physician review                               12 542                       All causes                     All age groups                      CSMFs accuracy, relationship between estimated CSMFs and true CSMFs
  Adapted WHO VA instrument ([@CIT0026])       Physician review                                                  12 542                       All causes                     All age groups                      Average of cause-specific chance-corrected concordance, CSMFs accuracy, Relationship between estimated CSMFs and true CSMFs
  Adapted WHO VA instrument ([@CIT0027])       Tariff method and physician review                                12 542                       All causes                     All age groups                      Average of cause-specific chance-corrected concordance, CSMFs accuracy, Relationship between estimated CSMFs and true CSMFs
  Adapted WHO VA instrument ([@CIT0028])       SSP method and physician review                                   12 542                       All causes                     All age groups                      Average of cause-specific chance-corrected concordance, CSMFs accuracy, Relationship between estimated CSMFs and true CSMFs
  Adapted WHO VA instrument ([@CIT0006])       Random Forests method and physician review                        12 542                       All causes                     All age groups                      Average of cause-specific chance-corrected concordance, CSMFs accuracy, Relationship between estimated CSMFs and true CSMFs
  INDEPTH VA instrument ([@CIT0029])           Physician review and InterVA                                      1 823                        All causes                     Children under 5 years and adults   Level of agreement between InterVA and physician assigned CoD using Kappa statistics, Concordance of CSMFs estimated by InterVA and physician review
  INDEPTH VA instrument ([@CIT0030])           Physician review and InterVA                                      10 267                       All causes                     All age groups                      Level of agreement between InterVA and physician assigned CoD using Kappa statistics
  INDEPTH VA instrument ([@CIT0031])           Physician review and InterVA                                      289                          All causes                     All age groups                      Concordance of CSMFs between InterVA and physician review
  Adapted INDEPTH VA instrument ([@CIT0032])   InterVA                                                           193                          HIV/AIDS                       Adults                              Sensitivity, Specificity, PPV, Concordance of CSMFs between InterVA and the reference standard, Level of agreement between InterVA and reference standard CoD using Kappa statistics, ROC curves
  SAVVY instrument ([@CIT0033])                Physician review and InterVA                                      145                          All causes                     Adults                              Sensitivity, Specificity, PPV, NPV, ROC curves, Level of agreement between InterVA, physician review and hospital CoD using Kappa statistics, Concordance of CSMFs between InterVA, physician review and hospital CoD
  Adapted SAVVY instrument ([@CIT0034])        Physician review                                                  264                          HIV/AIDS                       Adults                              Specificity, PPV
  LSHTM VA instrument ([@CIT0035])             Physician review and algorithms                                   615                          All causes                     Adults                              Sensitivity, Specificity, Concordance of CSMF obtained using the data-derived algorithms with the CSMF obtained using physician review
  LSHTM VA instrument ([@CIT0036])             Physician review and expert algorithms                            796                          All causes                     Adults                              Sensitivity, Specificity, PPV, Concordance of CSMFs between physician review, algorithms and hospital CoD
  LSHTM VA instrument ([@CIT0037])             Physician review, expert algorithms and data-derived algorithms   796                          All causes                     Adults                              Sensitivity, Specificity, Concordance of CSMFs between physician review, algorithms and hospital CoD
  LSHTM VA instrument ([@CIT0038])             Data-derived algorithms                                           40                           All causes                     Adults                              Kappa statistics

Our review of VA studies published up to 2012 highlights variability in the selection, development, and use of VA instruments, as well as in methods of assessment. The review established that there are many adaptations of standard VA instruments. Although instruments may need to be adapted to local contexts, the extent of modifications was not reported by studies and their impact on VA performance and accuracy are not known. The review was hindered by an absence of information on the VA instrument used by a substantial number of studies. The lack of systematic detailed information on methods used undermines the value of experience sharing on use of VA instruments and limits a more accurate understanding of the use of the different instruments and uptake of VA guidelines. Some reports on using VA may have been missed if written in other languages or as yet unpublished.

Simplification of VA standards: the 2012 WHO VA instrument {#S0003}
==========================================================

In December 2011, following the above review process, consensus over a simplified VA instrument was reached among 37 experts from 15 countries in a meeting organized by WHO in collaboration with the University of Queensland, the Health Metrics Network and INDEPTH. The meeting was followed by a 2-day workshop during which the outcomes of the discussions were consolidated. Participants included key stakeholders, researchers, and those who work routinely with VA instruments. The 2012 WHO VA instrument comprises a total of 221 CoD-related indicators to certify 62 CoD. The instrument is designed primarily for electronic data capture, and WHO data collection software will facilitate this on generic mobile devices. CoD interpretation software also allows assessment without physicians, reducing cost and time lag in VA interpretation, and enhancing comparability across different settings and over time. For those wanting to use paper capture and PCVA, simplified sample questionnaires have been developed for three age groups: under 4 weeks; 4 weeks to 14 years; and 15 years and over, which are available with all other aspects of the 2012 WHO VA instrument at [www.who.int/healthinfo/statistics/verbalautopsystandards](http://www.who.int/healthinfo/statistics/verbalautopsystandards)

As determined by extensive skip patterns, the maximum number of questions to be asked for any death ranges from 104 for a neonatal death to 130 for a maternal death ([Table 5](#T0005){ref-type="table"}). Although users may need to add locally relevant questions, the instrument as defined here should be regarded as the core.

###### 

Pattern of indicators by age group

                      Number of indicators                                      
  ------------------- ---------------------- ---- ---- ---- ----- ---- --- ---- -----
  15+ years           56                     37   27   10   130   26   3   10   169
  4 weeks--14 years   34                     35   22   10   101   26   3   10   140
  Under 28 days       44                     35   15   10   104   26   3   10   143
  Total               93                     87   31   10   221                 

Simplified list of CoD {#S0004}
======================

To develop a VA instrument appropriate for strengthening countries' CRVS systems, we simplified the WHO VA standards; this commenced with generating a shorter list of CoD. Three main criteria characterized essential CoD:Importance: most frequent CoD of global public health relevance (e.g. acute respiratory infections);Diagnostic Feasibility: CoD associated with recognizable symptoms ascertainable by VA (e.g. HIV/AIDS); andPotential for intervention: CoD can be addressed by public health interventions (e.g. diarrhoeal diseases).

Comparison of the results of most widely used and validated VA instruments and interpretation approaches including PCVA, InterVA, and Population Health Metrics Research Consortium (PHMRC) methods, enabled the identification of a core group of CoD that can be certified by VA. This core group of CoD was mapped against the 31 causes reported in the 2004 Global Burden of Disease (GBD) study to ascertain the public health importance of individual causes. Finally, consensus on the simplified list of CoD was reached in the meeting with VA experts, based on their experience and available evidence.

In the 2007 WHO VA standards, there were 106 possible CoD to be assigned by physicians, while InterVA-3 and InterVA-M assigned 48 causes and the PHMRC VA instrument reached 51 ([@CIT0005], [@CIT0031], [@CIT0039]). To facilitate comparison, some CoD from the WHO VA standards were re-categorized, creating a set of mutually exclusive, collectively exhaustive CoD categories. [Table 6](#T0006){ref-type="table"} displays the results from the review and correlation of CoD between the VA instruments and the GBD.

###### 

Correspondence of CoD between the 2007 WHO VA standards, InterVA and PHMRC VA instruments, the 2004 GBD, and their reported percentage in 125 reviewed VA studies

  2007 WHO VA standards                                          2004 GBD   InterVA   PHMRC VA instrument   \% Reported in various studies
  -------------------------------------------------------------- ---------- --------- --------------------- --------------------------------
  Infectious and parasitic diseases                                                                         
  Sepsis                                                                    •         •                     10.4
   Acute respiratory infection, including pneumonia              •          •         •                     37.6
   HIV/AIDS related death                                        •          •         •                     36.8
   Intestinal infectious diseases                                •          •         •                     40.8
   Malaria                                                       •          •         •                     33.6
   Measles                                                       •          •         •                     10.4
   Meningitis                                                    •          •         •                     30.4
   Tetanus                                                                  •                               4.8
   Pulmonary tuberculosis                                        •          •         •                     35.2
   Typhoid and Paratyphoid                                                                                  0.8
   Pertussis                                                     •                                          2.4
   Leishmaniasis                                                                                            0
   Viral hepatitis                                                                                          6.4
   Arthropod-borne viral fevers and viral haemorrhagic fevers                         •                     4.0
   Other infectious disease, unspecified                                    •         •                     21.6
  Neoplasms                                                                                                 
   Oral neoplasms                                                •                                          4.0
   Digestive neoplasms                                           •                    •                     12.0
   Malignant neoplasm of rectum and anus                         •                    •                     4.8
   Respiratory neoplasms                                         •                    •                     8.0
   Breast neoplasms                                              •                    •                     4.8
   Reproductive neoplasms                                        •                    •                     10.4
   Melanoma of skin                                                                                         0
   Neoplasm of lymphoid, haematopoietic and related tissue                                                  0.8
   Other and unspecified neoplasms                                          •         •                     20.0
  Nutritional and endocrine disorders                                                                       
   Severe anaemia                                                                                           9.6
   Severe malnutrition                                           •          •                               16.0
   Diabetes mellitus                                             •          •         •                     14.4
   Other and unspecified nutritional and endocrine disorders                                                1.6
  Diseases of circulatory system                                                                            
   Acute cardiac disease                                         •          •         •                     16.0
   Sickle cell                                                              •                               0.8
   Cerebrovascular disease                                       •          •         •                     22.4
   Other and unspecified cardiac disease                                              •                     44.0
  Respiratory disorders                                                                                     
   Chronic obstructive pulmonary disease (COPD)                                       •                     6.4
   Asthma                                                                             •                     4.8
   Other and unspecified respiratory disease                                •                               20.8
  Gastrointestinal diseases                                                                                 
   Acute abdominal condition                                                                                6.4
   Chronic liver disorder                                        •          •         •                     16.0
   Other and unspecified digestive disease                                  •         •                     13.6
  Renal disorders                                                                                           
   Renal failure                                                 •          •         •                     14.4
   Other and unspecified disorders of kidney and ureter                                                     2.4
   Mental and nervous system disorders                                                                      
   Mental disorder                                                                                          2.4
   Disease of nervous system                                                •                               3.2
   Epilepsy/Acute seizures                                                            •                     4.8
  Pregnancy-, childbirth and puerperium-related disorders                                                   
   Ectopic pregnancy                                                        •                               1.6
   Abortion-related death                                                   •                               4.0
   Pregnancy-induced hypertension                                           •                               9.6
   Obstetric haemorrhage                                                    •                               12.8
   Obstructed labour                                                        •                               5.6
   Pregnancy-related sepsis                                                 •                               8.8
   Anaemia of pregnancy                                                     •                               1.6
   Ruptured uterus                                                          •                               3.2
   Other and unspecified maternal cause                                     •         •                     20.8
  Perinatal causes of death                                                                                 
   Prematurity                                                   •          •         •                     35.2
   Perinatal asphyxia                                            •          •         •                     29.6
   Neonatal pneumonia                                            •                    •                     8.8
   Neonatal sepsis                                               •                    •                     20.8
   Neonatal tetanus                                              •                                          10.4
   Congenital malformation                                       •          •         •                     27.2
   Other diseases related to the perinatal period, unspecified                                              12.0
   Stillbirth                                                                         •                     8.0
  External causes                                                                                           
   Road traffic accident                                         •          •         •                     9.6
   Other transport accident                                      •          •                               7.2
   Accidental fall                                                          •         •                     6.4
   Accidental drowning and submersion                                       •         •                     9.6
   Accidental exposure to smoke, fire and flames                 •          •         •                     7.2
   Contact with venomous animals and plants                                 •         •                     3.2
   Accidental poisoning and exposure to noxious substance                   •         •                     5.6
   Intentional self-harm                                         •          •         •                     15.2
   Assault, homicide, war                                        •          •         •                     14.3
   Exposure to force of nature                                                                              0
   Lack of food and/or water                                                                                0
   Legal intervention                                                                                       0
   Accident, unspecified                                                    •                               14.4
   Other and unspecified external cause                                     •         •                     25.6

In the review of 125 studies covering 199,158 deaths described above, we collated evidence on CoD certified by VA and reported in studies to illustrate the range of CoD that were observed and certifiable by VA. The top 10 CoD reported were: 'other and unspecified cardiac disease' (44%); 'intestinal infectious diseases' (40.8%); 'acute respiratory infections, including pneumonia' (37.6%); 'HIV/AIDS-related death' (36.8%); 'pulmonary tuberculosis' (35.2%); 'prematurity' (35.2%); 'malaria' (33.6%); 'perinatal asphyxia' (29.6%); 'congenital malformations' (27.2%); and 'Other and unspecified external cause of death' (25.6%). In contrast, the 10 CoD certified and reported least frequently were: 'typhoid and paratyphoid' (0.8%); 'neoplasm of lymphoid, haematopoietic and related tissue' (0.8%); 'sickle cell' (0.8%); 'ectopic pregnancy' (1.6%); 'anaemia of pregnancy' (1.6%); 'other and unspecified nutritional and endocrine disorders' (1.6%); 'other and unspecified disorders of kidney and ureter' (2.4%); 'mental disorder' (2.4%); 'pertussis' (2.4%); and 'disease of nervous system' (3.2%). The CoD 'Leishmaniasis', 'melanoma of skin', 'exposure to force of nature', 'lack of food and/or water', and 'legal intervention' have not been certified by VA in any of the reviewed studies.

Elimination of CoD was based on low frequency reported by VA studies, not being included in the other VA instruments, and on experts' judgment about their importance, feasibility and intervention potential. As a result, 27 CoD from the 2007 WHO VA standards were subsumed into residual categories, including 'typhoid and paratyphoid', 'leishmaniasis', 'melanoma of skin', 'lack of food and/or water' and 'legal intervention' ([Table 7](#T0007){ref-type="table"}).

###### 

CoD removed from CoD list of the 2007 WHO VA standard and subsumed into other categories in 2012 WHO standard (*n*=27)

  2007 WHO VA standard cause                                          Subsumed into 2012 WHO VA cause
  ------------------------------------------------------------------- ---------------------------------
  Other digestive disease                                             VAs-98
  Typhoid and paratyphoid                                             VAs-01.99
  Viral hepatitis                                                     VAs-01.99
  Leishmaniasis                                                       VAs-01.99
  Malignant melanoma of skin                                          VAs-02.99
  Malignant neoplasm of lymphoid, haematopoietic and related tissue   VAs-02.99
  Other specified neoplasms                                           VAs-02.99
  Other specified endocrine disorders                                 VAs-98
  Endocrine disorders, unspecified                                    VAs-98
  Other specified diseases of the respiratory system                  VAs-98
  Respiratory disorder, unspecified                                   VAs-98
  Respiratory failure, not elsewhere classified                       VAs-98
  Other diseases of intestine                                         VAs-98
  Disease of intestine, unspecified                                   VAs-98
  Specified mental disorders                                          VAs-98
  Mental disorders, unspecified                                       VAs-98
  Other specified disorders of the nervous system                     VAs-98
  Nervous system disorders, not otherwise classified                  VAs-98
  Alzheimer\'s disease                                                VAs-98
  Other specified direct maternal causes                              VAs-09.99
  Congenital viral diseases                                           VAs-01.99
  Congenital malformations of the nervous system                      VAs-10.06
  Other specified disorders related to perinatal period               VAs-10.99
  Lack of food and/or water                                           VAs-12.99
  Legal intervention                                                  VAs-12.99
  Accident, unspecified                                               VAs-12.99
  Other specified event, undetermined intent                          VAs-12.99

The inclusion of the majority of CoD in the simplified CoD list was based on the consistency between CoD from WHO VA standards against InterVA and PHMRC VA, GBD estimates and coverage in VA studies. All causes included in the GBD and the top 10 most certified CoD reported were retained. During expert meetings, the CoD 'other and unspecified non-communicable disease', 'sepsis', 'anaemia of pregnancy' and 'ruptured uterus' were added to the list. Although not in the GBD or most commonly certified CoD, they were considered feasible for VA certification, provide key information to CRVS, contribute significant mortality burdens and are responsive to interventions. Further modifications included grouping related CoD not having readily distinguishable symptoms into broader categories. For example, 'malignant neoplasm of cervix' and 'malignant neoplasm of uterus' were combined into 'female reproductive neoplasms'. Overall, the simplification process led to a 41.5% reduction in CoD compared with the WHO VA standards CoD list, resulting in 60 CoD. A further two categories were added for fresh and macerated stillbirths, despite not strictly considered as CoD, because of their importance in some settings. [Table 8](#T0008){ref-type="table"} presents the simplified VA CoD list, structuring the causes into groupings consistent with ICD-10 and showing in the last column how all ICD-10 codes map onto the 62 CoD.

###### 

Simplified CoD list for 2012 WHO VA with corresponding ICD-10 codes

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  2012 verbal autopsy code   Verbal autopsy title                                      ICD-10 code (to ICD)         ICD-10 codes (from ICD)
  -------------------------- --------------------------------------------------------- ---------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  VAs-01                     Infectious and parasitic diseases                                                      

  VAs-01.01                  Sepsis                                                    A41                          A40--A41

  VAs-01.02                  Acute respiratory infection, including pneumonia          J22; J18                     J00--J22

  VAs-01.03                  HIV/AIDS related death                                    B24                          B20--B24

  VAs-01.04                  Diarrheal diseases                                        A09                          A00--A09

  VAs-01.05                  Malaria                                                   B54                          B50--B54

  VAs-01.06                  Measles                                                   B05                          B05

  VAs-01.07                  Meningitis and encephalitis                               G03; G04                     A39; G00--G05

  VAs-01.08                  Tetanus                                                   A35 (obstetric A34)          A33--A35

  VAs-01.09                  Pulmonary tuberculosis                                    A16                          A15--A16

  VAs-01.10                  Pertussis                                                 A37                          A37

  VAs-01.11                  Haemorrhagic fever                                        A99                          A90--A99

  VAs-01.99                  Other and unspecified infectious disease                  B99                          A20--A38; A42--A89; B00--B19; B25--B49; B55--B99

                             Non-communicable diseases                                                              

  VAs-98                     Other and unspecified non-communicable disease            R99                          D55--D89; E00--E07; E15--E35; E50--E90; F00--F99; G10--G37; G50--G99; H00--H95; J30--J39; J47--J99; K00--K31; K40--K93; L00--L99; M00--M99; N00--N16; N20--N99; R00--R69

  VAs-02                                                                                                            Neoplasms

  VAs-02.01                  Oral neoplasms                                            C06                          C00--C06

  VAs-02.02                  Digestive neoplasms                                       C26                          C15--C26

  VAs-02.03                  Respiratory neoplasms                                     C39                          C30--C39

  VAs-02.04                  Breast neoplasms                                          C50                          C50

  VAs-02.05                  Female reproductive neoplasms                             C57                          C51--C58

  VAs-02.06                  Male reproductive neoplasms                               C63                          C60--C63

  VAs-02.99                  Other and unspecified neoplasms                           C80                          C07--C14; C40--C49; C60--D48

  VAs-03                     Nutritional and endocrine disorders                                                    

  VAs-03.01                  Severe anaemia                                            D64                          D50--D64

  VAs-03.02                  Severe malnutrition                                       E46                          E40--E46

  VAs-03.03                  Diabetes mellitus                                         E14                          E10--E14

  VAs-04                     Diseases of the circulatory system                                                     

  VAs-04.01                  Acute cardiac disease                                     I24 (acute ischemic)         I20--I25

  VAs-04.02                  Stroke                                                    I64                          I60--I69

  VAs-04.03                  Sickle cell with crisis                                   D57                          D57

  VAs-04.99                  Other and unspecified cardiac disease                     I99                          I10--I15; I26--I52; I70--I99

  VAs-05                     Respiratory disorders                                                                  

  VAs-05.01                  Chronic obstructive pulmonary disease (COPD)              J44                          J40--J44

  VAs-05.02                  Asthma                                                    J45 (J46)                    J45--J46

  VAs-06                     Gastrointestinal disorders                                                             

  VAs-06.01                  Acute abdomen                                             R10                          R10

  VAs-06.02                  Liver cirrhosis                                           K74                          K70--K76

  VAs-07                                                                                                            Renal disorders

  VAs-07.01                  Renal failure                                             N19                          N17--N19

  VAs-08                     Mental and nervous system disorders                                                    

  VAs-08.01                  Epilepsy                                                  G40                          G40--G41

  VAs-09                     Pregnancy-, childbirth and puerperium-related disorders                                

  VAs-09.01                  Ectopic pregnancy                                         O00                          O00

  VAs-09.02                  Abortion-related death                                    O06                          O03--O08

  VAs-09.03                  Pregnancy-induced hypertension                            O13 (or O15 for eclampsia)   O10--O16

  VAs-09.04                  Obstetric haemorrhage                                     O46 (antepartum)\            O46; O67; O72
                                                                                       O72 (postpartum)             

  VAs-09.05                  Obstructed labour                                         O66                          O63--O66

  VAs-09.06                  Pregnancy-related sepsis                                  O75.3 (antepartum)\          O85; O75.3
                                                                                       O85 (postpartum)             

  VAs-09.07                  Anaemia of pregnancy                                      O99                          O99.0

  VAs-09.08                  Ruptured uterus                                           O71                          O71

  VAs-09.99                  Other and unspecified maternal cause                      O05                          O01--O02; O20--O45; O47--O62; O68--O70; O73--O84; O86--O99

  VAs-10                     Neonatal causes of death                                                               

  VAs-10.01                  Prematurity                                               P07                          P05--P07

  VAs-10.02                  Birth asphyxia                                            P21                          P20--P22

  VAs-10.03                  Neonatal pneumonia                                        P23                          P23--P25

  VAs-10.04                  Neonatal sepsis                                           P63                          P36

  VAs-10.05                  Neonatal tetanus                                          A33                          A33

  VAs-10.06                  Congenital malformation                                   Q89                          Q00--Q99

  VAs-10.99                  Other and unspecified perinatal cause of death            P96                          P00--P04; P08--P15; P26--P35; P37--P94; P96

  VAs-11                     Stillbirths                                                                            

  VAs-11.01                  Fresh stillbirth                                          P95                          P95

  VAs-11.02                  Macerated stillbirth                                      P95                          P95

  VAs-12                     External causes of death                                                               

  VAs-12.01                  Road traffic accident                                     V89                          V01--V89

  VAs-12.02                  Other transport accident                                  V99                          V90--V99

  VAs-12.03                  Accidental fall                                           W19                          W00--W19

  VAs-12.04                  Accidental drowning and submersion                        W74                          W65--W74

  VAs-12.05                  Accidental exposure to smoke, fire and flames             X09                          X00--X19

  VAs-12.06                  Contact with venomous animals and plants                  X29                          X20--X29

  VAs-12.07                  Accidental poisoning and exposure to noxious substance    X49                          X40--X49

  VAs-12.08                  Intentional self-harm                                     X84                          X60--X84

  VAs-12.09                  Assault                                                   Y09                          X85--Y09

  VAs-12.10                  Exposure to force of nature                               X39                          X30--X39

  VAs-12.99                  Other and unspecified external cause of death             X59                          S00--T99; W20--W64; W75--W99; X50--X59; Y10--Y98

  VA-99                      Cause of death unknown                                    R99                          R99
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

VA questionnaires and indicators {#S0005}
================================

VA questionnaires ask specific questions about signs, symptoms, complaints, or contextual factors that will lead to determining the most probable CoD. Such information that indicates the possibility of specific causes is inclusively termed as 'indicators'. The review aimed to collate evidence from field experience on: (i) specific modifications made to VA questionnaires and their rationales; (ii) utility of specific indicators for CoD ascertainment; and (iii) identification of most and least specific indicators for reaching diagnoses. From the 125 studies reviewed, contact was attempted with 45 randomly selected authors (one per study, unless referred to another), and established with 27. Limited feedback was gathered on specific indicators, as most researchers were not able to report on specific modifications made to the VA instruments, and they found it challenging to give feedback on the utility, value and specificity of individual questionnaire indicators. The following alterations to standard instruments were reported:Structural rearrangement of order and categorization of questionnaire modules and changes in targeted age groups;Attempts to shorten the VA questionnaires by removal and modification of questions related to the duration of signs and symptoms; andAddition of disease-specific questions for local conditions and research needs.

Overall, users considered the 2007 WHO VA standards too long and time-consuming, expressing a desire for shorter and more practical instruments. This process of simplification was started by drafting diagnostic criteria for each CoD by listing symptoms indicated in the Oxford Text Book of Medicine ([@CIT0040]). Subsequently, experts identified essential indicators for differentiating CoD, and inclusion/exclusion was based on likely recognition, recollection, and reporting in VA interviews. Evidence of indicators' utility was gathered by correlating indicators from WHO VA standards, InterVA, and PHMRC VA procedures. Furthermore, the simplification of the WHO VA standards indicators was informed by a progressive item reduction process based on the Tariff method ([@CIT0027]). Participating experts from PHMRC had applied the Tariff method to the PHMRC validation dataset and tested the effect of dropping items or sets of items on chance-corrected concordance and CSMF accuracy. These findings comprised one element of the discussion on the evidence base for some CoD. Indicators removed had low specificity and possibly generated answers with low reliability due to recall difficulties. These were mainly sub-indicators on the duration, frequency, and development of signs and symptoms. Other modifications made included the addition of indicators from InterVA and PHMRC VA instruments, the removal of overlapping indicators capturing very similar information, and the inclusion of social context indicators, facilitating use of the instrument in non-enumerated populations. Overall, 164 indicators were retained from the 2007 WHO VA standard, 57 new indicators introduced and 244/408 indicators from the 2007 WHO VA standard excluded. Review by expert groups -- for relevance to the list of causes, reliability, and feasibility -- and comparison with machine assessment analysis led to a reduction of 45.8% in number of CoD-related indicators in relation to the WHO VA standards, resulting in a total of 221 indicators (of which various subsets apply to particular population sub-groups).

Application of the 2012 WHO VA instrument to facilitate routine surveillance {#S0006}
============================================================================

The need for consensus on simplified technical standards and guidelines for VA, together with their widespread endorsement and adoption, has become urgent. The systematic use of the 2012 WHO VA instrument will strengthen countries' CRVS systems. In the past decade, methodological developments in automated methods for VA assessment have created a shift away from limited individual-level and clinical paradigms towards population-based epidemiological and public health thinking. To facilitate application in routine surveillance systems, the new simplified VA instrument was specifically developed for automated ascertainment of CoD. At present, the InterVA-4 model, as previously described ([@CIT0041]), is the only available automated interpretation tool fully aligned with the 2012 WHO VA instrument. A simple, automatically interpreted VA process will lead to increased coverage of operational and representative CRVS systems. Shorter and simpler interviews not needing physicians for CoD interpretation will facilitate collection of adequate data for CRVS systems. CCVA brings efficiency and consistency by providing a standardized interpretation of VA. The new 2012 WHO VA instrument will be piloted, modified, and integrated into national health information systems.

INDEPTH ([www.indepth-network.org](http://www.indepth-network.org)) is a network of member centres that conduct longitudinal health and demographic evaluation of populations in LMICs. INDEPTH has built a network of 44 health and demographic surveillance systems (HDSS) across 20 countries in Africa, Asia, and Oceania. The network strengthens capacity of HDSS centres, and mounts multicentre research to guide health priorities and policies in LMICs, based on up-to-date empirical scientific evidence. The network uses VA as a method for determining CoD.

SAVVY, proposed by MEASURE Evaluation and the International Programs Center, U.S. Census Bureau, is a system to generate reliable information on mortality levels and CoD at the national level. The SAVVY resource library is a series of best practice manuals and methods for improving the quality of vital statistics where high coverage of civil registration and good CoD data are not available. A SAVVY system collects mortality data from a number of sites throughout a country using multistage probability sampling. SAVVY Methods include determination of CoD with VA.
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